The Interventional Effect of Remote Ischemic Preconditioning on Cerebral Small Vessel Disease: A Pilot Randomized Clinical Trial

European Neurology

Volumn 76, Issue 1-2, 2016, Pages 28-34

  Mi, Taomian ^a   Yu, Fei ^a   Ji, Xunming ^a   Sun, Yongxin ^a   Qu, Dongmei ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BRAIN DAMAGE; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISABILITY; DIZZINESS; DOUBLE BLIND PROCEDURE; FAMILY HISTORY; FEMALE; HEMODYNAMICS; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIC PRECONDITIONING; LACUNAR STROKE; LIMB ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC PRECONDITIONING; REPERFUSION; TRANSIENT ISCHEMIC ATTACK; UPPER LIMB; WHITE MATTER LESION; CEREBRAL SMALL VESSEL DISEASES; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CEREBRAL SMALL VESSEL DISEASES; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 84976559475     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000447536     Document Type: Article

References (46)

1. Pantoni L: Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701.
2. Wu B, Lin S, Hao Z, Yang J, Xu Y, Wu L, Zhang S, Liu M: Proportion, risk factors and outcome of lacunar infarction: a hospitalbased study in a Chinese population. Cerebrovasc Dis 2010; 29: 181-187.
3. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia: Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association. Stroke 2011; 42: 2672-2713.
4. Weber R, Weimar C, Blatchford J, Hermansson K, Wanke I, Möller-Hartmann C, Gizewski ER, Forsting M, Demchuk AM, Sacco RL, Saver JL, Warach S, Diener HC, Diehl A; PRoFESS Imaging Substudy Group: Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke 2012; 43: 2336-2342.
5. ten Dam VH, van den Heuvel DM, van Buchem MA, Westendorp RG, Bollen EL, Ford I, de Craen AJ, Blauw GJ; PROSPER Study Group: Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64: 1807-1809.
6. SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-825.
7. Cocho D, Belvís R, Martí-Fabregas J, Bravo Y, Aleu A, Pagonabarraga J, Molina-Porcel L, Díaz-Manera J, San Roman L, Martínez-Lage M, Martínez A, Moreno M, Martí-Vilalta JL: Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol 2006; 55: 70-73.
8. Vlasov TD, Korzhevski DE, Poliakova EA: [Ischemic adaptation of the rat brain as a method for protection of endothelium from ischemic reperfusion injury]. Ross Fiziol Zh Im I M Sechenova 2004; 90: 40-48.
9. Vlasov TD, Korzhevskii DE, Polyakova EA: Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury. Neurosci Behav Physiol 2005; 35: 567-572.
10. Rehni AK, Shri R, Singh M: Remote ischaemic preconditioning and prevention of cerebral injury. Indian J Exp Biol 2007; 45: 247-252.
11. Ren C, Gao X, Steinberg GK, Zhao H: Limb remote-preconditioning protects against focal ischemia in rats and contradicts the dogma of therapeutic time windows for preconditioning. Neuroscience 2008; 151: 1099-1103.
12. Hahn CD, Manlhiot C, Schmidt MR, Nielsen TT, Redington AN: Remote ischemic perconditioning: a novel therapy for acute stroke? Stroke 2011; 42: 2960-2962.
13. Meng R, Asmaro K, Meng L, Liu Y, Ma C, Xi C, Li G, Ren C, Luo Y, Ling F, Jia J, Hua Y, Wang X, Ding Y, Lo EH, Ji X: Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology 2012; 79: 1853-1861.
14. Jacobson GP, Newman CW: The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 1990; 116: 424-427.
15. Koch S, Katsnelson M, Dong C, Perez-Pinzon M: Remote ischemic limb preconditioning after subarachnoid hemorrhage: a phase Ib study of safety and feasibility. Stroke 2011; 42: 1387-1391.
16. Li L, Luo W, Huang L, Zhang W, Gao Y, Jiang H, Zhang C, Long L, Chen S: Remote perconditioning reduces myocardial injury in adult valve replacement: a randomized controlled trial. J Surg Res 2010; 164:e21-e26.
17. Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT: Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010; 375: 727-734.
18. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, et al: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
19. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, Barkhof F, Fazekas F: White matter lesion progression: a surrogate endpoint for trials in cerebral smallvessel disease. Neurology 2004; 63: 139-144.
20. Cho AH, Kim HR, Kim W, Yang DW: White matter hyperintensity in ischemic stroke patients: it may regress over time. J Stroke 2015; 17: 60-66.
21. Rodríguez García PL, Rodríguez García D: Diagnosis of vascular cognitive impairment and its main categories. Neurologia 2015; 30: 223-239.
22. Pantoni L, Poggesi A, Inzitari D: The relation between white-matter lesions and cognition. Curr Opin Neurol 2007; 20: 390-397.
23. Benjamin P, Zeestraten E, Lambert C, Ster IC, Williams OA, Lawrence AJ, Patel B, Mac-Kinnon AD, Barrick TR, Markus HS: Progression of MRI markers in cerebral small vessel disease: sample size considerations for clinical trials. J Cereb Blood Flow Metab 2016; 36: 228-240.
24. Tuladhar AM, van Norden AG, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, de Leeuw FE: White matter integrity in small vessel disease is related to cognition. Neuroimage Clin 2015; 7: 518-524.
25. Roubec M, Kuliha M, Jonszta T, Procházka V, Fadrná T, Filip M, Kanovsky P, Langová K, Herzig R, Skoloudík D: Detection of intracranial arterial stenosis using transcranial colorcoded duplex sonography, computed tomographic angiography, and digital subtraction angiography. J Ultrasound Med 2011; 30: 1069-1075.
26. Zhou Y, Hua Y, Jia L, Wang L, Liu B, Duan C, Jiao L: Evaluation of interventional therapy for patients with intracranial vertebral artery stenosis by transcranial color-coded sonography. Ultrasound Med Biol 2016; 42: 44-50.
27. Jia L, Hua Y, Li J, Duan C, Zhou Y, Jiao L: Optimal ultrasound criteria for defining the severity of vertebral artery in-stent restenosis. Ultrasound Med Biol 2015; 41: 775-780.
28. Nedelmann M, Stolz E, Gerriets T, Baumgartner RW, Malferrari G, Seidel G, Kaps M: Consensus recommendations for transcranial color-coded duplex sonography for the assessment of intracranial arteries in clinical trials on acute stroke. Stroke 2009; 40: 3238-3244.
29. Kidwell CS, el-Saden S, Livshits Z, Martin NA, Glenn TC, Saver JL: Transcranial Doppler pulsatility indices as a measure of diffuse small-vessel disease. J Neuroimaging 2001; 11: 229-235.
30. Chamorro A, Pujol J, Saiz A, Vila N, Vilanova JC, Alday M, Blanc R: Periventricular white matter lucencies in patients with lacunar stroke. A marker of too high or too low blood pressure? Arch Neurol 1997; 54: 1284-1288.
31. Legarth J, Thorup E: Characteristics of Doppler blood-velocity waveforms in a cardiovascular in vitro model. I. The model and the influence of pulse rate. Scand J Clin Lab Invest 1989; 49: 451-457.
32. Mok V, Ding D, Fu J, Xiong Y, Chu WW, Wang D, Abrigo JM, Yang J, Wong A, Zhao Q, et al: Transcranial Doppler ultrasound for screening cerebral small vessel disease: a community study. Stroke 2012; 43: 2791-2793.
33. Kim JT, Lee SH, Hur N, Jeong SK: Blood flow velocities of cerebral arteries in lacunar infarction and other ischemic strokes. J Neurol Sci 2011; 308: 57-61.
34. Schmidt EA, Piechnik SK, Smielewski P, Raabe A, Matta BF, Czosnyka M: Symmetry of cerebral hemodynamic indices derived from bilateral transcranial Doppler. J Neuroimaging 2003; 13: 248-254.
35. Rodríguez Hernández SA, Kroon AA, van Boxtel MP, Mess WH, Lodder J, Jolles J, de Leeuw PW: Is there a side predilection for cerebrovascular disease? Hypertension 2003; 42: 56-60.
36. Chang CC, Chang WN, Huang CR, Liou CW, Lin TK, Lu CH: The relationship between isolated dizziness/vertigo and the risk factors of ischemic stroke: a case control study. Acta Neurol Taiwan 2011; 20: 101-106.
37. Wu CC, Young YH: Association between leukoaraiosis and saccadic oscillation. Arch Otolaryngol Head Neck Surg 2007; 133: 245-249.
38. Walsh SR, Nouraei SA, Tang TY, Sadat U, Carpenter RH, Gaunt ME: Remote ischemic preconditioning for cerebral and cardiac protection during carotid endarterectomy: results from a pilot randomized clinical trial. Vasc Endovascular Surg 2010; 44: 434-439.
39. Gonzalez NR, Hamilton R, Bilgin-Freiert A, Dusick J, Vespa P, Hu X, Asgari S: Cerebral hemodynamic and metabolic effects of remote ischemic preconditioning in patients with subarachnoid hemorrhage. Acta Neurochir Suppl 2013; 115: 193-198.
40. Hougaard KD, Hjort N, Zeidler D, Sørensen L, Nørgaard A, Hansen TM, von Weitzel-Mudersbach P, Simonsen CZ, Damgaard D, Gottrup H, et al: Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke 2014; 45: 159-167.
41. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ: Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol 2005; 46: 450-456.
42. Schoemaker RG, van Heijningen CL: Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000; 278:H1571-H1576.
43. Patel HH, Moore J, Hsu AK, Gross GJ: Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol 2002; 34: 1317-1323.
44. Thompson JW, Dave KR, Young JI, Perez-Pinzon MA: Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance. Neurotherapeutics 2013; 10: 789-797.
45. Sabbagh S, Henry Salzman MM, Kloner RA, Simkhovich BZ, Rezkalla SH: Remote ischemic preconditioning for coronary artery bypass graft operations. Ann Thorac Surg 2013; 96: 727-736.
46. Liu XQ, Sheng R, Qin ZH: The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 2009; 30: 1071-1080.